May 2, 2024 | Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…

The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.
New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.
With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.
Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Moshe Safran, CEO at RSIP Vision USA, delves into a range of topics around computer vision, AI, and deep learning in medical imaging, surgery, and healthcare, including the work that…
We invite you to join Impetus Digital and the Medical Affairs Professional Society (MAPS) on February 19, 10 am EST, for a thought-provoking webinar around the future of virtual events.
Dr. Donald Rucker, National Coordinator at the Office of the National Coordinator for Health Information Technology (ONC Health IT), explores all things medical and clinical informatics and “Health IT.” Among other…
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints.
Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, delves into a number of interesting topics such as the importance of emotional intelligence, patient-centric solutions, and adopting a growth…
Liam Kaufman, CEO & Co-founder of Winterlight Labs, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital, for this live Fireside Chat. Today, we are exploring a range of topics…
Dr. Shurjeel Choudhri, SVP and Head, Medical and Scientific Affairs at Bayer Canada, dives into a range of hot topics, from innovative digital technologies and beyond-the-pill medicine to the concept of patient-centricity….
Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital, for this live Fireside Chat. Today, we are exploring…
Remote work is here to stay. Learn how companies and employees can thrive in this new environment
Dr. Roxie Mooney, Healthcare Commercialization Strategist at Legacy DNA and best-selling author, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital. We are discussing all things healthcare innovation and commercialization,…
